Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/21 03:20:41 am
402.75 EUR   -0.80%
01/04SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
2021SARTORIUS VORZUEGE : NorldLB gives a Neutral rating
MD
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius Significantly Expands Activities in South Korea

11/24/2021 | 11:42pm EST

Sartorius is investing around EUR 270 million, some USD 300 million, through the end of 2024 in expanding its activities in South Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell culture media production and to assemble sterile systems for efficient and flexible manufacturing of biopharmaceuticals, among other operations. This investment responds to the dynamic development of the South Korean market as well as of further Asian markets. Construction of the company's facilities on the property site covering some 25,000 square meters, or close to 270,000 square feet, will include an application center with laboratories as well as several buildings for manufacturing and logistics. In total, jobs for approximately 750 people will be created there. Sartorius' existing activities for service as well as marketing and sales will relocate to the new site under development, which offers space for further extensions. Construction work at the site is slated to begin in the coming year, and production operations are scheduled to start by the end of 2024. Sartorius has been operating a sales and service office in South Korea for more than 30 years. Currently, more than 180 people work at this location for Sartorius.


© S&P Capital IQ 2021
All news about SARTORIUS AG
01/04SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
2021SARTORIUS VORZUEGE : NorldLB gives a Neutral rating
MD
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
2021Sartorius To Buy 63% Interest In Germany's ALS Automated Lab Solutions
MT
2021Sartorius Aktiengesellschaft entered into an agreement to acquire a 62.5% stake in ALS ..
CI
2021SARTORIUS : and HOF Sonderanlagenbau Partnership Creates...
PU
2021Sartorius to Pay $11.3 Million COVID-19 Bonus to Employees
MT
2021SARTORIUS : employees to receive a bonus for their commitment and...
PU
2021Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
2021Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2021 3 397 M 3 847 M 3 847 M
Net income 2021 418 M 473 M 473 M
Net Debt 2021 1 885 M 2 136 M 2 136 M
P/E ratio 2021 68,2x
Yield 2021 0,33%
Capitalization 30 331 M 34 393 M 34 356 M
EV / Sales 2021 9,48x
EV / Sales 2022 8,27x
Nbr of Employees 12 952
Free-Float 33,3%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 406,00 €
Average target price 488,55 €
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-18.64%34 393
REVENIO GROUP OYJ-10.17%1 503
BIOTAGE AB (PUBL)-28.02%1 365
VAREX IMAGING CORPORATION-12.27%1 095
CELLAVISION AB (PUBL)-1.60%837
RENALYTIX PLC-10.65%547